Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$SDVI ~ One of the most undervalued stocks!!!
https://www.otcmarkets.com/stock/SDVI/overview
$SDVI ~ One of the most undervalued stocks!!!
https://www.otcmarkets.com/stock/SDVI/overview
Load em' up!!! $RSII
Chart is SCREAMING for a reversal! $RSII
http://stockcharts.com/h-sc/ui
Is that another bullish harami on the chart today?! Second one within this week... A reversal is imminent! $RSII
I have my shares locked at $2!! $RSII
Cannophen news would be amazing!! Maybe getting the product out there state to state... make national news on the war against Opioids!
$RSII
An unexpected PR would be amazing! $RSII
L2 should show that it isn't that difficult to get through to .001 and break that. $SDVI
Easily one of the most undervalued stocks! We should be trading at least at .01 IMHO
$SDVI
Smart move! $RSII will be heading back up. Oversold.. again! We are looking at another rebound, especially if we close at Unch or green today.
$SDVI ~ easily one of the most undervalued stocks out there! Currently at .0005
This company should be trading at a minimum of .01 IMHO
$SDVI ~ easily one of the most undervalued stocks out there! Currently at .0005
This company should be trading at a minimum of .01 IMHO
$SDVI ~ Announces 50% Revenue Increase for Q1 2018
IRVINE, CA, May 04, 2018 (GLOBE NEWSWIRE) -- Signature Devices, Inc. (OTC PINK: SDVI) today announced that its revenues increased to around $75k in Q1 2018, which is a 50% increase in revenues vs Q4 of 2017. The company also announced that it reached near break even for the quarter in net revenue.
Innovo Technology’s second year as a public company is off to a great start without even going into full production of its flagship Morpheus Pro product line or the full launch of the innovative Knoton.
The company spent 2017 focusing on further developing the award-winning Morpheus products that generated a net positive income in Q3 2017, while hitting $140k total revenue in 2017. The company has already generated 50% of total revenue of 2017 in Q1 of 2018 and has lots of big plans for the rest of the year. “Innovo Technologies is a start-up in every sense and because we are public, our value isn’t nearly where it should be. Private companies in our space see valuations 20-30 times where we are currently. However, we are uniquely positioned for explosive growth once we secure the necessary resources for the planned expansion” said Inas Azzam, CEO of Signature Devices.
Most recently, Innovo announced the launch of a kickstarter campaign focused on its most innovative product to date, the Knoton; a highly customizable IoT device focused on school safety, personal security and blockchain-based secure transactions.
The full report will be filed on 5/15/2018 and will be available at https://www.otcmarkets.com/stock/SDVI/disclosure
You can also follow the company on Twitter for small updates and announcements, https://twitter.com/SignatureDevice
About Innovo Technology, Inc.
Based in Irvine, California, Innovo Technology combines the best of the technologies underpinning the popular Morpheus media server, Tazerwear's AI Software, Truck IT's beacon platform with Knoton's hardware, infrastructure and software. The result is a company that blends custom software and powerful hardware IoT-interconnected devices. Learn more by visiting: http://innovotech.io/about/
About Signature Devices, Inc.
Based in Sheridan, Wyoming, Signature Devices, Inc. (www.signaturedevices.com) (OTC PINK: SDVI) is a holding company with subsidiaries that develop Internet of Things (IOT) products through its subsidiary Innovo Technologies, Inc., and publishes diverse media products including video games and mobile applications through its subsidiary Graffiti Entertainment, Inc.
Forward-Looking Statements:
The information in this press release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.
Signature Devices, Inc.
Investors Relations
ir@signaturedevices.com
650-654-4800 ext 111
http://www.signaturedevices.com
https://www.otcmarkets.com/stock/SDVI/news/Signature-Devices-Inc-Announces-50-Revenue-Increase-for-Q1-2018?id=191290
$SDVI ~ Announces 50% Revenue Increase for Q1 2018
IRVINE, CA, May 04, 2018 (GLOBE NEWSWIRE) -- Signature Devices, Inc. (OTC PINK: SDVI) today announced that its revenues increased to around $75k in Q1 2018, which is a 50% increase in revenues vs Q4 of 2017. The company also announced that it reached near break even for the quarter in net revenue.
Innovo Technology’s second year as a public company is off to a great start without even going into full production of its flagship Morpheus Pro product line or the full launch of the innovative Knoton.
The company spent 2017 focusing on further developing the award-winning Morpheus products that generated a net positive income in Q3 2017, while hitting $140k total revenue in 2017. The company has already generated 50% of total revenue of 2017 in Q1 of 2018 and has lots of big plans for the rest of the year. “Innovo Technologies is a start-up in every sense and because we are public, our value isn’t nearly where it should be. Private companies in our space see valuations 20-30 times where we are currently. However, we are uniquely positioned for explosive growth once we secure the necessary resources for the planned expansion” said Inas Azzam, CEO of Signature Devices.
Most recently, Innovo announced the launch of a kickstarter campaign focused on its most innovative product to date, the Knoton; a highly customizable IoT device focused on school safety, personal security and blockchain-based secure transactions.
The full report will be filed on 5/15/2018 and will be available at https://www.otcmarkets.com/stock/SDVI/disclosure
You can also follow the company on Twitter for small updates and announcements, https://twitter.com/SignatureDevice
About Innovo Technology, Inc.
Based in Irvine, California, Innovo Technology combines the best of the technologies underpinning the popular Morpheus media server, Tazerwear's AI Software, Truck IT's beacon platform with Knoton's hardware, infrastructure and software. The result is a company that blends custom software and powerful hardware IoT-interconnected devices. Learn more by visiting: http://innovotech.io/about/
About Signature Devices, Inc.
Based in Sheridan, Wyoming, Signature Devices, Inc. (www.signaturedevices.com) (OTC PINK: SDVI) is a holding company with subsidiaries that develop Internet of Things (IOT) products through its subsidiary Innovo Technologies, Inc., and publishes diverse media products including video games and mobile applications through its subsidiary Graffiti Entertainment, Inc.
Forward-Looking Statements:
The information in this press release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.
Signature Devices, Inc.
Investors Relations
ir@signaturedevices.com
650-654-4800 ext 111
http://www.signaturedevices.com
https://www.otcmarkets.com/stock/SDVI/news/Signature-Devices-Inc-Announces-50-Revenue-Increase-for-Q1-2018?id=191290
$RSII ~ Bullish Harami Cross spotted!!
http://stockcharts.com/h-sc/ui?s=rsii
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=RSII
$RSII ~ Bullish Harami Cross spotted!!
http://stockcharts.com/h-sc/ui?s=rsii
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=RSII
Word is getting out from American Bulls on the chart!
https://twitter.com/search?f=tweets&q=%24rsii&src=typd&lang=en
https://www.candlesticker.com/Pattern.aspx?lang=en&Pattern=2103
$RSII
$RSII ~ Bullish Harami Cross on the chart!
http://stockcharts.com/h-sc/ui
$RSII ~ Bullish Harami Cross on the chart!
http://stockcharts.com/h-sc/ui
BULLISH HARAMI CROSS FORMED on the chart!! Beautiful close!! $RSII
Nice!!! Lots of sales going through! $RSII
Let's close green here! $RSII
Whoever bought the scar cream please remember to write a review on Amazon! $RSII
https://www.amazon.com/RBS0238-CLINICAL-STRENGTH-PEPTIDE-COMPLEX/dp/B07CJKTZ2M/ref=sr_1_31_s_it?s=hpc&ie=UTF8&qid=1525278234&sr=1-31&keywords=scar+peptide
Looks like bullish harami is setting in on the chart today... BEAUTIFUL!! $RSII
Absolutely! Here is the short report for $RSII
https://otcshortreport.com/company/rsii
New product to be in production $RSII
"Rising Biosciences team is thrilled to announce that their next product moving into production is its RBS0346 Clinical Strength Stem Cell Cream."
I smell much revenues coming through.... $$$$ $RSII
$RSII ~ Product on AMAZON... Revenues are on their way!
Search "scar peptide" and our product is on the second page! HUGE
https://www.amazon.com/RBS0238-CLINICAL-STRENGTH-PEPTIDE-COMPLEX/dp/B07CJKTZ2M/ref=sr_1_31_s_it?s=hpc&ie=UTF8&qid=1525278234&sr=1-31&keywords=scar+peptide
We filed for name/ticker change with FINRA in May 2017. It took NWAV one year after filing to become PAOG (our sister company). Also, we used the same attorneys who filed that paper work to file ours. The ticker name that has been chosen is RBIO.
We are now in May 2018... do the math folks! $$$$$$$$$
$RSII
.05+
I am no chart expert, but I recall someone posting that there is a bearish harami that was formed on the chart. However, I don't believe so because a bearish harami doji would fall within the previous trading days doji, and in our case, the previous close was .0155 and our price open was .0155, which kept us in the "safe" zone. Not worried here at all. I am looking for another spike to break through .03 by the end of the month. $RSII
Just with a quick Amazon search of "scar peptide" you will see our product on the second page! That's huge!!!!
https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Dhpc&field-keywords=scar+peptide
$RSII
$SDVI ~ HUGE News today under the radar! Super Undervalued @ .0004
Signature Devices Morpheus Wins Prestigious SVI Award
IRVINE, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Signature Devices, Inc. (OTC PINK: SDVI) today announced that two of its Morpheus Products have won in the Prestigious SVI Trade Awards.
Morpheus faced some tough competition against very well known and global brands. The SVI Awards are a “close-fought competition as you, the industry, elect all your CI and AV aces in 2018’s LILIN-sponsored SVI Awards. As with every year, free from any inside attempts to further any judging panel’s own favorites, all votes came entirely from the industry, meaning that the SVI Trade Awards are not only fairer than a fair maiden fairy judging a fairness competition at a village fair at Fairness-on-Sea, but also that to win is to gain an accolade not from us, but from your industry peers themselves.” The award is given out to products “who were deemed perfectionist enough to earn a place,” according to SVI.
Morpheus won bronze in the BEST DIGITAL AUDIO STREAMER category coming in after Denon and Yamaha.
The big win for Morpheus was in the BEST MEDIA SERVER category where Morpheus took home the Gold beating out Netflix and Kaleidescape.
“I am very proud of this achievement,” Said Inas Azzam, CEO of SDVI. “This is a big honor and a big win for us. To be judged by professionals and our peers in the industry as one of the best has given Morpheus much due recognition. I also give thanks to the hard working team at Indigo Distribution in the UK for believing in and representing our brand,” He went on to say.
The SVI awards can be see here: https://www.svimag.com/index.php/content/news/svi_trade_awards_winners_announced
Learn more about Morpheus here: http://www.morpheusav.com
About Innovo Technology, Inc.
Based in Irvine, California, Innovo Technology combines the best of the technologies underpinning the popular Morpheus media server, Tazerwear's AI Software, Truck IT's beacon platform with Knoton's hardware, infrastructure and software. The result is a company that blends custom software and powerful hardware IoT-interconnected devices. Learn more by visiting: http://innovotech.io/about/
$SDVI ~ HUGE News today under the radar! Super Undervalued @ .0004
Signature Devices Morpheus Wins Prestigious SVI Award
IRVINE, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Signature Devices, Inc. (OTC PINK: SDVI) today announced that two of its Morpheus Products have won in the Prestigious SVI Trade Awards.
Morpheus faced some tough competition against very well known and global brands. The SVI Awards are a “close-fought competition as you, the industry, elect all your CI and AV aces in 2018’s LILIN-sponsored SVI Awards. As with every year, free from any inside attempts to further any judging panel’s own favorites, all votes came entirely from the industry, meaning that the SVI Trade Awards are not only fairer than a fair maiden fairy judging a fairness competition at a village fair at Fairness-on-Sea, but also that to win is to gain an accolade not from us, but from your industry peers themselves.” The award is given out to products “who were deemed perfectionist enough to earn a place,” according to SVI.
Morpheus won bronze in the BEST DIGITAL AUDIO STREAMER category coming in after Denon and Yamaha.
The big win for Morpheus was in the BEST MEDIA SERVER category where Morpheus took home the Gold beating out Netflix and Kaleidescape.
“I am very proud of this achievement,” Said Inas Azzam, CEO of SDVI. “This is a big honor and a big win for us. To be judged by professionals and our peers in the industry as one of the best has given Morpheus much due recognition. I also give thanks to the hard working team at Indigo Distribution in the UK for believing in and representing our brand,” He went on to say.
The SVI awards can be see here: https://www.svimag.com/index.php/content/news/svi_trade_awards_winners_announced
Learn more about Morpheus here: http://www.morpheusav.com
About Innovo Technology, Inc.
Based in Irvine, California, Innovo Technology combines the best of the technologies underpinning the popular Morpheus media server, Tazerwear's AI Software, Truck IT's beacon platform with Knoton's hardware, infrastructure and software. The result is a company that blends custom software and powerful hardware IoT-interconnected devices. Learn more by visiting: http://innovotech.io/about/
Will May be the month for name/ticker change? Hmmmm
Again, EXCELLENT DD!!
$RSII --> $RBIO
$RSII News:
Rising Biosciences Announces Official Sales and Distribution of its RSB0238 Clinical Strength Peptide Complex on Amazon®
$RSII RSB0238 Clinical Strength Peptide Complex now available on Amazon.com!
Rising India, Inc.
RSII’s serum ranks among top best-sellers in its category
SANDUSKY, Ohio, May 01, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.'s Rising Biosciences (OTC:RSII) (“RSII” “the Company”), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that Amazon® is now officially stocking and fulfilling orders via Amazon distribution centers throughout the USA for the Company’s revolutionary RSB0238 Clinical Strength Peptide Complex. (product link: https://www.amazon.com/dp/B07CJKTZ2M/ref=cm_sw_r_other_apa_mi31Ab5X0TMAY)
Amazon Prime members receive free two day shipping on the serum, which debuted to 5-star reviews and ranked among the best-selling new releases in the facial serum category.
COO Arthur Hall commented: “This is the first of many RSII products that we’ll be offering via Amazon distribution centers throughout the United States with all order fulfillment performed directly by Amazon. RSII has achieved a highly desirable relationship here, and one we intend to further cultivate. I hope that it is clear to all that this is a monumental achievement for RSII that I believe will propel RSII to the next level of growth. That being said, We are also working with a broker to establish a presence in nationally recognized brick and mortar stores throughout the country.”
Rising Biosciences team is thrilled to announce that their next product moving into production is its RBS0346 Clinical Strength Stem Cell Cream.
Hall comments, “It’s safe to say that the anti-aging skin care market is not slowing down anytime soon. The global skin care industry is estimated to reach $131 billion in 2019 and we intend to capture an impactful market share as we continue to innovate and deliver products with unparalleled effect.”
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opioids on America through the responsible use of cannabis”
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.
CONTACT INFO:
For Investor Inquiries:
IR@risingbiosciences.com
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/e084556d-19e8-47b4-a4fe-2e8f8896ecdc
http://globenewswire.com/news-release/2018/05/01/1494289/0/en/Rising-Biosciences-Announces-Official-Sales-and-Distribution-of-its-RSB0238-Clinical-Strength-Peptide-Complex-on-Amazon.html
$RSII News:
Rising Biosciences Announces Official Sales and Distribution of its RSB0238 Clinical Strength Peptide Complex on Amazon®
$RSII RSB0238 Clinical Strength Peptide Complex now available on Amazon.com!
Rising India, Inc.
RSII’s serum ranks among top best-sellers in its category
SANDUSKY, Ohio, May 01, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.'s Rising Biosciences (OTC:RSII) (“RSII” “the Company”), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that Amazon® is now officially stocking and fulfilling orders via Amazon distribution centers throughout the USA for the Company’s revolutionary RSB0238 Clinical Strength Peptide Complex. (product link: https://www.amazon.com/dp/B07CJKTZ2M/ref=cm_sw_r_other_apa_mi31Ab5X0TMAY)
Amazon Prime members receive free two day shipping on the serum, which debuted to 5-star reviews and ranked among the best-selling new releases in the facial serum category.
COO Arthur Hall commented: “This is the first of many RSII products that we’ll be offering via Amazon distribution centers throughout the United States with all order fulfillment performed directly by Amazon. RSII has achieved a highly desirable relationship here, and one we intend to further cultivate. I hope that it is clear to all that this is a monumental achievement for RSII that I believe will propel RSII to the next level of growth. That being said, We are also working with a broker to establish a presence in nationally recognized brick and mortar stores throughout the country.”
Rising Biosciences team is thrilled to announce that their next product moving into production is its RBS0346 Clinical Strength Stem Cell Cream.
Hall comments, “It’s safe to say that the anti-aging skin care market is not slowing down anytime soon. The global skin care industry is estimated to reach $131 billion in 2019 and we intend to capture an impactful market share as we continue to innovate and deliver products with unparalleled effect.”
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opioids on America through the responsible use of cannabis”
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.
CONTACT INFO:
For Investor Inquiries:
IR@risingbiosciences.com
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/e084556d-19e8-47b4-a4fe-2e8f8896ecdc
http://globenewswire.com/news-release/2018/05/01/1494289/0/en/Rising-Biosciences-Announces-Official-Sales-and-Distribution-of-its-RSB0238-Clinical-Strength-Peptide-Complex-on-Amazon.html
I was invested here a while ago. Knew this day would be coming. Congrats to all of you longs and new investors who saw the potential here. Any company that is against opioid abuse will certainly be a winner in the near future. Congrats again, folks!
Excellent DD WSK! It is clear to see that all the dots are connecting here. I am anticipating the change from $RSII to $RBIO ... any day now... Tick Tock...
$RSII
.05+